Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

Abstract. Atypical haemolytic uraemic syndrome (aHUS) may clinically present as acute renal graft failure resulting from excessive activation of the complement

Saved in:

Bibliographic Details
Main Authors:	Münch, Johannes (Author) , Bachmann, Anette (Author) , Kirschfink, Michael (Author)
Format:	Article (Journal)
Language:	English
Published:	10 July 2017
In:	Clinical kidney journal Year: 2017, Volume: 10, Issue: 6, Pages: 742-746
ISSN:	2048-8513
DOI:	10.1093/ckj/sfx053
Online Access:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/ckj/sfx053 Verlag, kostenfrei, Volltext: https://academic.oup.com/ckj/article/10/6/742/3947937
Author Notes:	Johannes Münch, Anette Bachmann, Maik Grohmann, Christof Mayer, Michael Kirschfink, Tom H. Lindner, Carsten Bergmann and Jan Halbritter

Description
Summary:	Abstract. Atypical haemolytic uraemic syndrome (aHUS) may clinically present as acute renal graft failure resulting from excessive activation of the complement
Item Description:	Gesehen am 28.08.2018
Physical Description:	Online Resource
ISSN:	2048-8513
DOI:	10.1093/ckj/sfx053